Alkyl-CoA disulfides as inhibitors and mechanistic probes for FabH enzymes

被引:52
作者
Alhamadsheh, Marnoun M.
Musayev, Faik
Komissarov, Andrey A.
Sachdeva, Sarbjot
Wright, H. Tonie
Scarsdale, Neel
Florova, Galina
Reynolds, Kevin A. [1 ]
机构
[1] Portland State Univ, Dept Chem, Portland, OR 97207 USA
[2] Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA 23219 USA
[3] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23219 USA
[4] Virginia Commonwealth Univ, Dept Biochem, Richmond, VA 23219 USA
来源
CHEMISTRY & BIOLOGY | 2007年 / 14卷 / 05期
关键词
D O I
10.1016/j.chembiol.2007.03.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The first step of the reaction catalyzed by the homodimeric FabH from a dissociated fatty acid synthase is acyl transfer from acyl-CoA to an active site cysteine. We report that C-1 to C-10 alkyl-CoA disulfides irreversibly inhibit Escherichia coli FabH (ecFabH) and Mycobacterium tuberculosis FabH with relative efficiencies that reflect these enzymes' differential acyl-group specificity. Crystallographic and kinetic studies with MeSSCoA show rapid inhibition of one monomer of ecFabH through formation of a methyl disulfide conjugate with this cysteine. Reaction of the second subunit with either MeSSCoA or acetyl-CoA is much slower. In the presence of malonyl-ACP, the acylation rate of the second subunit is restored to that of the native ecFabH. These observations suggest a catalytic model in which a structurally disordered apo-ecFabH dimer orders on binding either the first substrate, acetyl-CoA, or the inhibitor MeSSCoA, and is restored to a disordered state on binding of malonyl-ACP.
引用
收藏
页码:513 / 524
页数:12
相关论文
共 57 条
  • [1] Synthesis and biological evaluation of thiazolidine-2-one 1,1-dioxide as inhibitors of Escherichia coli β-ketoacyl-ACP-synthase III (FabH)
    Alhamadsheh, Mamoun M.
    Waters, Norman C.
    Huddler, Donald P.
    Kreishman-Deitrick, Mara
    Florova, Galina
    Reynolds, Kevin A.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (04) : 879 - 883
  • [2] Probing the mechanism of the Mycobacterium tuberculosis β-ketoacyl-acyl carrier protein synthase III mtFabH -: Factors influencing catalysis and substrate specificity
    Brown, AK
    Sridharan, S
    Kremer, L
    Lindenberg, S
    Dover, LG
    Sacchettini, JC
    Besra, GS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (37) : 32539 - 32547
  • [3] Crystallography & NMR system:: A new software suite for macromolecular structure determination
    Brunger, AT
    Adams, PD
    Clore, GM
    DeLano, WL
    Gros, P
    Grosse-Kunstleve, RW
    Jiang, JS
    Kuszewski, J
    Nilges, M
    Pannu, NS
    Read, RJ
    Rice, LM
    Simonson, T
    Warren, GL
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 : 905 - 921
  • [4] TOM - A FRODO SUBPACKAGE FOR PROTEIN-LIGAND FITTING WITH INTERACTIVE ENERGY MINIMIZATION
    CAMBILLAU, C
    HORJALES, E
    [J]. JOURNAL OF MOLECULAR GRAPHICS, 1987, 5 (04): : 174 - &
  • [5] Choi KH, 2000, J BIOL CHEM, V275, P28201
  • [6] β-ketoacyl-acyl carrier protein synthase III (FabH) is a determining factor in branched-chain fatty acid biosynthesis
    Choi, KH
    Heath, RJ
    Rock, CO
    [J]. JOURNAL OF BACTERIOLOGY, 2000, 182 (02) : 365 - 370
  • [7] CLOUGH RC, 1992, J BIOL CHEM, V267, P20992
  • [8] EVIDENCE FOR A THIOL REAGENT INHIBITING CHOLINE-ACETYLTRANSFERASE BY REACTING WITH THIOL-GROUP OF COENZYME-A FORMING A POTENT INHIBITOR
    CURRIER, SF
    MAUTNER, HG
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1976, 69 (02) : 431 - 436
  • [9] INTERACTION OF ANALOGS OF COENZYME-A WITH CHOLINE-ACETYLTRANSFERASE
    CURRIER, SF
    MAUTNER, HG
    [J]. BIOCHEMISTRY, 1977, 16 (09) : 1944 - 1948
  • [10] First X-ray cocrystal structure of a bacterial FabH condensing enzyme and a small molecule inhibitor achieved using rational design and homology modeling
    Daines, RA
    Pendrak, I
    Sham, K
    Van Aller, GS
    Konstantinidis, AK
    Lonsdale, JT
    Janson, CA
    Qiu, XY
    Brandt, M
    Khandekar, SS
    Silverman, C
    Head, MS
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (01) : 5 - 8